SUMMARY We describe 2 extended kindreds supposedly manifesting familial multiple adenomatous polyposis coli (FPC) (Bussey, 1975) . Recently, the clinical spectrum of FPC has been expanded to include associated syndromes (Gardner's, Turcot's, and others) in which adenomatous polyps occur in the colon and occasionally throughout the gastrointestinal tract and/or which are distinguished by benign and malignant neoplasms of other anatomical sites (Yonemoto et al., 1969) .
Descriptions of familial adenomatous polyposis of the colon (FPC) show the classical phenotype as including myriad adenomatous polyps along the entire length of the colon and rectum. Affected patients who do not undergo prophylactic colectomy have a virtual 100% likelihood of developing colon cancer by the age of 50 (Bussey, 1975) . Recently, the clinical spectrum of FPC has been expanded to include associated syndromes (Gardner's, Turcot's, and others) in which adenomatous polyps occur in the colon and occasionally throughout the gastrointestinal tract and/or which are distinguished by benign and malignant neoplasms of other anatomical sites (Yonemoto et al., 1969) .
To the extent that limited polyp expression occurs among supposed 'polyposis' patients, more reliable minimal diagnostic criteria characterising the phenotype will be required before the polyposis coli genotype and its cancer proclivity can be inferred. Received for publication 8 June 1978 Materials and methods Two families (C-205, C-210) were studied in accordance with medical-genetic protocols used for acquisition of detailed genealogical and medical history. Particular emphasis was given to thorough description of the number and anatomical distribution of adenomatous polyps in the colon and other areas of the gastrointestinal tract, as well as their association with carcinoma of the colon and other anatomical sites. Questionnaires were used for the initial gathering of historical data. Signed permission forms helped in the retrieval of primary hospital, physician, and pathology records. In spite of the high rate of successful medical record retrieval in these families, a number of the medical and pathology documents contained either limited or imprecise descriptions: for example, 'huge' polyps (no precise measurements given); polyps located at the 'lower section' of the colon; or polyps described as 'multiple' but lacking more accurate quantification. These, of course, are shortcomings inherent in the retrospective method of such family studies. Con (Bussey, 1975 Lockhart-Mummery (1925) . Families comprising this registry have been described by others (Lockhart-Mummery, 1925; Dukes, 1930; Veale, 1965; Bussey, 1975) . Dukes (1951) recognised variability in the clinical expression of adenomatous polyps in FPC families, but emphasised a narrow set of criteria for its classical presentation: onset of isolated adenomatous polyps by approximately age 20, usually in the rectum and sigmoid colon, followed by a fairly rapid increase in number, to cover most or all of the colon by age 30. This, if untreated by colectomy, is then followed almost invariably by colonic cancer, generally by age 40 or 45. Because this phenotype has generally been regarded as a clearly defined entity, FPC has frequently been cited as a model for the study of hereditary cancer predisposing disease (Dukes, 1930 (Utsunomiya and Nakamura, 1975; Danes et al., 1977) .
The extensive phenotypic features seen in the disorders listed in Table 2 contrast sharply with the observation of familial aggregation of solitary polyps in a single extended pedigree (Woolf and Gardner, 1950; Woolf et al., 1955) . These authors considered the aggregation of solitary polyps to be a distinct genetic entity, rather than the result of incomplete penetrance of the polyposis gene. This supposition was undoubtedly reinforced by the absence of diffuse polyposis coli in any patients from the family.
Maintenance of the clear distinction between FPC and the described solitary colorectal polyp syndrome (McKusick, 1962 ) has been made difficult by our observation of the 2 families which include both patients with diffuse polyposis coli (classical FPC) and patients with only solitary polyps, but in whom the colon cancer predisposition appears to beequally high.
Variation in the phenotypic presentation of polyps in a kindred raises a question as to the minimal frequency and/or distribution of colon polyps required to establish an FPC diagnosis. In other words, is there some arbitrary minimum number of polyps and/or a particular anatomical site distribution required for securely establishing the FPC diagnosis (and, hence, genotypic status)? As recently as 1970, it was stated (Morson and Bussey, 1970 ) that in polyposis coli 'evidence suggests that there are never fewer than about 200 polyps', though 100 may be a more generally accepted figure. In a family which has members with known diffuse polyposis and others with only isolated colonic polyps, this distinction is particularly critical since reliance upon an arbitrary minimum number may cause the physician to overlook the potentially harmful character of isolated polyps, if they should in fact represent limited expression of FPC in carriers of the deleterious gene.
Conversely, it is known that more than 5 % of the adult American population have one or more solitary polyps (Swinton, 1954; Myers and Bacon, 1960 (Lipkin and Deschner, 1976) . The description of families with variable polyp expression has been hampered by the reluctance or inability of many investigators to focus on the problem of heterogeneity per se. This has been due in part to: (1) inadequate or non-existent surgical pathological description of the quantity, distribution, and histological classification of colonic polyps, particularly in patients affected before the advent of modern diagnostic and surgical techniques; and (2) uncritical acceptance by geneticists and clinicians of such inadequately documented cases to which diffuse polyposis with its genetic implication is evidently ascribed.
Asman and Pierce (1970) reported a large kindred which included 8 patients categorised as having 'deduced polyposis', that is, those who died of colon cancer and had a child with polyposis, notwithstanding the fact that records of the patients with 'deduced polyposis' showed no documented evidence of this trait. They also described a class of 'polyposis carriers', that is, those having no clinical evidence of a gastrointestinal tract disorder, but who had children with polyposis.
The survey of the St. Mark's polyposis registry (Dukes, 1951) showed colonic polyposis in only about 60% of the patients with colorectal cancer. Furthermore, there was insufficient description of cases of 'polyposis' to determine how many of these patients definitely exhibited the classical phenotype. Bussey (1975) , using more recent data from the St. Mark's registry, established 5 classes of 'polyposis' patients, according to criteria similar to that of Asman and Pierce (1970) . Four of the 5 classes of patients (about half of the subject population) lacked histological evidence of polyposis, but were included because of symptoms consistent with it, that is, colon cancer or polyps of unknown histological status and/or pedigree relation to a known affected patient. In terms of genotype status such 6 classifications may be valid; nevertheless, inferences about their phenotype must be made with caution.
The marked heterogeneity of polyp expression in families has led to the establishment of at least one genetic model to explain this variability. Veale (1965) has proposed a model in which one of three allelic genes may occur at a particular gene locus: P (classical polyposis); p (recessive, causing only solitary polyps in the pp state), and x (normal). The observation of multiple polyposis and isolated polyps in a single sibship could thus be explained in terms of segregation of P, p, and x alleles.
Critical analysis of actual pedigree data, however, suggests three limitations in this simple genetic model. (1) The portion of family C-205 shown in Fig. 1 shows a mother (111.4) known to have only solitary polyps (putative pp), and a son (IV.1) with classical polyposis (putative Pp or Px). Assuming that the contribution of a P from the father is excluded and reduced penetrance of a P in the mother is ruled out, those elements of Veale's hypothesis which attribute isolated polyps to a Mendelian recessive gene would have to be largely refuted. In other words, segregation of P, p, and x alleles in this kindred would be impossible in the light of the known polyp expression in several members. Thus, our data suggest that variable pentrance of the dominant P gene is a more valid (though obviously less elegant) explanation of the patterns seen in these pedigrees. (2) Veale's model could not explain the apparent dominant transmission of solitary polyps in families reported previously (Woolf et al., 1955) . Furthermore, in our own family 'R' (Lynch et al., 1977 (Lynch et al., , 1978 there were 34 cases of gastrointestinal tract carcinoma (only 4 of which were by history alone). None of the more than 20 patients for whom adequate pathological description was available had more than 10 polyps located in the colon. Yet, autosomal dominant transmission of colon cancer has been supported through genetic analysis (Lynch et al., 1977 (Lynch et al., , 1978 , and more recently by segregation analysis (R. C. Elston et al., 1978, unpublished data) using maximum pedigree likelihood methods (Elston and Stewart, 1971) . (3) The high degree of verification required for reliable classification (polyposis versus isolated polyps versus normal) is extremely difficult, if not impossible, to obtain on a retrospective basis for more than two consecutive generations (as our own somewhat arbitrary categorisations have shown).
It is noteworthy that in family C-205, the progenitor female (Fig. 1, M.4 (or, as in this case, all) progeny.
In conclusion, the variable colon polyp expression described in the 2 subject kindreds raises several issues which have serious implications for patient management. Therapeutic and cancer surveillance options which could be presented to the patient include: (1) prophylactic colectomy in the presence of isolated colon polyps, notwithstanding a degree of uncertainty as to the patient's genotypic status; (2) longitudinal surveillance by periodic colonoscopy and/or barium enema with air contrast, and biannual evaluation for occult blood in the stool, with consideration given to eventual prophylactic colectomy should polyps show a progressive increase in number and/or size approaching the classical features of FPC.
We believe that our data, while limited to only 2 families, indicate the need for a more careful description of clinical signs, particularly the number, site, and distribution of colon polyps in high risk patients from families with a tendency to colon cancer and/or so-called classical FPC. These data also clearly show the need for research into the development of reliable biological markers to aid the recognition of genotype status and hence colon cancer risk.
